Metis Global Partners LLC Acquires 583 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Metis Global Partners LLC lifted its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 3.8% during the 3rd quarter, HoldingsChannel reports. The fund owned 15,982 shares of the medical device company’s stock after buying an additional 583 shares during the period. Metis Global Partners LLC’s holdings in Cooper Companies were worth $1,763,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of COO. Quent Capital LLC grew its position in Cooper Companies by 300.0% in the first quarter. Quent Capital LLC now owns 828 shares of the medical device company’s stock valued at $84,000 after acquiring an additional 621 shares during the period. Empowered Funds LLC bought a new stake in Cooper Companies during the 1st quarter worth approximately $256,000. QRG Capital Management Inc. acquired a new position in Cooper Companies in the first quarter worth $481,000. ProShare Advisors LLC lifted its position in Cooper Companies by 291.2% during the 1st quarter. ProShare Advisors LLC now owns 26,818 shares of the medical device company’s stock worth $2,721,000 after buying an additional 19,963 shares in the last quarter. Finally, Bleakley Financial Group LLC boosted its holdings in Cooper Companies by 346.3% in the first quarter. Bleakley Financial Group LLC now owns 5,373 shares of the medical device company’s stock valued at $545,000 after acquiring an additional 4,169 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Piper Sandler boosted their target price on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research report on Thursday, August 29th. Robert W. Baird lifted their price target on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research report on Thursday, August 29th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Thursday, August 29th. Stifel Nicolaus reissued a “buy” rating and issued a $115.00 target price (up from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Finally, StockNews.com upgraded Cooper Companies from a “hold” rating to a “buy” rating in a research report on Thursday. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Insider Transactions at Cooper Companies

In other news, CFO Brian G. Andrews sold 24,788 shares of the company’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the transaction, the chief financial officer now directly owns 6,614 shares in the company, valued at approximately $700,422.60. This represents a 78.94 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Daniel G. Mcbride sold 114,992 shares of the business’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the sale, the chief operating officer now owns 44,696 shares in the company, valued at $4,714,534.08. This represents a 72.01 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 256,373 shares of company stock worth $27,637,427. Company insiders own 2.00% of the company’s stock.

Cooper Companies Stock Performance

NASDAQ COO opened at $99.63 on Friday. The firm’s fifty day moving average price is $106.83 and its two-hundred day moving average price is $97.93. The Cooper Companies, Inc. has a 1 year low of $82.21 and a 1 year high of $112.38. The firm has a market capitalization of $19.84 billion, a P/E ratio of 55.50, a price-to-earnings-growth ratio of 2.20 and a beta of 0.99. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. The business had revenue of $1 billion for the quarter, compared to analysts’ expectations of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.84 EPS. As a group, research analysts anticipate that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.